MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX)

CUSIP: 556099109

Q3 2023 13F Holders as of 30 Sep 2023

Holder snapshot 7 signals
Share change
-1,966,326
Put/Call ratio
23%
SEC-reported price per share
$4.66
Number of holders
125
Value change
-$10,612,704
Number of buys
58
Open additional details 1 more signal available
Number of sells
61
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
63,537,462

Security key

556099109

Report period

Q3 2023

Institutions

125

Top holders

10

Ownership snapshot

Top reported holders of MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bellevue Group AG
Disclosed value leader
Bellevue Group AG
Comparable rows
0/15
Latest evidence
30 Jun 2023
13F Highest disclosed value: $51,413,035 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Bellevue Group AG has the largest disclosed position value at $51.41M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bellevue Group AG's linked filing trail.
Disclosed position value Top 5
Bellevue Group AG $51.41M
BlackRock Finance, Inc. $32.08M
ARMISTICE CAPITAL, LLC $29.96M
T. Rowe Price Investment Manageme... $29.23M
VANGUARD GROUP INC $23.44M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bellevue Group AG
13F
Company
13F
—
denominator unverified
$51,413,035
9,609,913 shares
— 30 Jun 2023
BlackRock Finance, Inc.
13F
Company
13F
—
mixed-class rows
$32,083,706
6,000,132 shares
mixed-class rows
— 30 Jun 2023
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$29,960,000
5,600,000 shares
— 30 Jun 2023
T. Rowe Price Investment Management, Inc.
13F
Company
13F
—
denominator unverified
$29,226,000
5,462,652 shares
— 30 Jun 2023
VANGUARD GROUP INC
13F
Company
13F
—
mixed-class rows
$23,437,184
4,394,602 shares
mixed-class rows
— 30 Jun 2023
Frazier Life Sciences Management, L.P.
13F
Company
13F
—
denominator unverified
$9,647,141
1,803,204 shares
— 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
125
Shares
58,037,496
Rows available
125
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
128
Q3 2023 holders
125
Holder diff
-3
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .